Table 1 ASDAS-CRP score in each group
N | ASDAS-CRP | Age | Sex M: F | |
|---|---|---|---|---|
Control group | 15 | 0.60 ± 0.00 | 17–59 (35.6 ± 13.8) | 9:6 |
Case group | 99 | 2.48 ± 1.27 | 14–71 (35.5 ± 13.6) | 60:39 |
Inactive group | 20 | 0.67 ± 0.12 | 17–54 (33.2 ± 10.6) | 7:13 |
Active group | 79 | 2.94 ± 0.98 | 14–71 (36.1 ± 14.3) | 53:26 |
Moderate activity group | 18 | 1.73 ± 0.26 | 17–71 (34.4 ± 13.2) | 10:8 |
High disease activity group | 42 | 2.86 ± 0.39 | 18–63 (36.8 ± 14.4) | 30:12 |
Very high disease activity group | 19 | 4.28 ± 0.63 | 14–70 (36.1 ± 15.6) | 13:6 |
Pre-treatment | 20 | 3.01 ± 0.84 | 17–54 (28.5 ± 9.9) | 11:9 |
After 3W of treatment | 20 | 1.61 ± 0.88 | – | – |
After 6W of treatment | 20 | 1.11 ± 0.59 | – | – |
After 12W of treatment | 20 | 0.75 ± 0.35 | – | – |